Ειδήσεις: BIOPHARMA | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 08:09 defenseworld.net

BioPharma Credit (LON:BPCP) Shares Down 0.2% – Time to Sell?

BioPharma Credit share price investment trust royalty‑secured debt market cap beta

25/03 08:06 defenseworld.net

Xencor’s (XNCR) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.

Xencor JPMorgan neutral rating price objective biopharma analyst coverage

25/03 07:26 defenseworld.net

Connect Biopharma (NASDAQ:CNTB) and BioMarin Pharmaceutical (NASDAQ:BMRN) Financial Comparison

Connect Biopharma BioMarin Pharmaceutical institutional ownership valuation insider holdings dividends

25/03 07:04 defenseworld.net

AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Wednesday

AEON Biopharma earnings forecast stock price hedge fund Geode Capital P/E ratio

25/03 07:04 defenseworld.net

Mereo BioPharma Group (MREO) Projected to Post Earnings on Wednesday

Mereo BioPharma Q4 earnings revenue consensus estimate NASDAQ MREO

24/03 23:24 investing.com

Grifols approves IPO of its US biopharma business

Grifols IPO US biopharma plasma therapeutics Spanish pharma capital raising

24/03 20:46 defenseworld.net

E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD

E. Ohman J Asset Management AB Gilead Sciences stock holdings biopharmaceutical

24/03 20:42 defenseworld.net

Insmed (NASDAQ:INSM) Price Target Cut to $175.00 by Analysts at Wells Fargo & Company

Insmed price target Wells Fargo Royal Bank of Canada Rothschild Weiss Ratings

24/03 19:39 defenseworld.net

1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co.

Congress Asset Management TG Therapeutics shares biopharma institutional investment hedge funds

24/03 19:39 defenseworld.net

1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co.

Congress Asset Management TG Therapeutics shares biopharma institutional investment hedge funds

Loading...